Metizol (Thiamazole)

Thiamazole, the active ingredient in Metizol, is an antithyroid agent presented as an oral tablet for oral use. It is used to treat hyperthyroidism, including Graves' disease, by reducing excess thyroid hormone production in adults and children. GNH USA supplies Metizol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metizol, an antithyroid medication, is employed in conditions where thyroid hormone overproduction is present. - Hyperthyroidism: lowers circulating thyroid hormones to achieve a euthyroid state. - Graves' disease: controls autoimmune stimulation of the thyroid, reducing symptoms and disease activity. - Toxic nodular goiter: diminishes hormone output from autonomous thyroid nodules.

Thiamazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Skin rash: localized itching or erythema. - Taste disturbance: altered taste perception. - Arthralgia: joint discomfort. - Mild liver enzyme elevation.

Serious or Rare Side Effects: - Agranulocytosis: severe drop in white blood cells, increasing infection risk. - Aplastic anemia: bone‑marrow suppression leading to pancytopenia. - Hepatic failure: significant liver injury. - Stevens‑Johnson syndrome: severe skin reaction. - Vasculitis: inflammation of blood vessels.

Before initiating Metizol, several safety considerations should be observed. - Blood count monitoring: perform baseline and periodic CBC to detect agranulocytosis. - Liver function tests: assess baseline enzymes and repeat if clinically indicated. - Hypersensitivity: discontinue if rash or angioedema develops. - Pregnancy: use only if benefits outweigh risks; discuss with obstetrician. - Renal impairment: dose may need adjustment in severe dysfunction. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Thiamazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin: thiamazole may potentiate anticoagulant effect, increasing INR. - Azole antifungals (e.g., ketoconazole): can raise thiamazole plasma levels. - Lithium: combined use may enhance hypothyroid effect.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of thyrotoxicosis. - Iodine‑containing contrast agents: can affect thyroid hormone dynamics. - Corticosteroids: may reduce antithyroid efficacy. - Oral contraceptives: possible alteration of hormone levels.